Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metformin ameliorates doxorubicin-induced cardiotoxicity targeting HMGB1/TLR4/NLRP3 signaling pathway in mice
Amany A. Alzokaky, Ahmed A. Al‐Karmalawy, Mohamed A. Saleh, et al.
Life Sciences (2023) Vol. 316, pp. 121390-121390
Closed Access | Times Cited: 21

Showing 21 citing articles:

Diabetes mellitus: Classification, mediators, and complications; A gate to identify potential targets for the development of new effective treatments
Samar A. Antar, Nada A. Ashour, Marwa Sharaky, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115734-115734
Open Access | Times Cited: 96
Neutrophil extracellular traps mediate cardiomyocyte ferroptosis via the Hippo–Yap pathway to exacerbate doxorubicin-induced cardiotoxicity
Peng Zhao, Li You, Xiangli Xu, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 10
The anti‐inflammatory effect of metformin: The molecular targets
Natsumi Sakata
Genes to Cells (2024) Vol. 29, Iss. 3, pp. 183-191
Open Access | Times Cited: 8
Protective effects of esculetin against doxorubicin‐induced toxicity correlated with oxidative stress in rat liver: In vivo and in silico studies
Zeynep Özdemir Köroğlu, Duygu Kizir, Melike Karaman, et al.
Journal of Biochemical and Molecular Toxicology (2024) Vol. 38, Iss. 4
Closed Access | Times Cited: 8
Sodium-glucose cotransporter 2 inhibitor dapagliflozin prevents ejection fraction reduction, reduces myocardial and renal NF-κB expression and systemic pro-inflammatory biomarkers in models of short-term doxorubicin cardiotoxicity
Vincenzo Quagliariello, Maria Laura Canale, Isabella Bisceglia, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access | Times Cited: 6
Review on the role of nucleotide-binding oligomerization domain-like receptor protein 3 (NLRP3) inflammasome pathway in diabetes: mechanistic insights and therapeutic implications
Abhishek Satheesan, Janardanan Kumar, K.V. Leela, et al.
Inflammopharmacology (2024) Vol. 32, Iss. 5, pp. 2753-2779
Closed Access | Times Cited: 4
Leucine zipper protein 1 prevents doxorubicin-induced cardiotoxicity in mice
Di Fan, Zhili Jin, Jianlei Cao, et al.
Redox Biology (2023) Vol. 64, pp. 102780-102780
Open Access | Times Cited: 11
HMGB1 as an extracellular pro-inflammatory cytokine: Implications for drug-induced organic damage
Jianye Yuan, Lin Guo, JiaTing Ma, et al.
Cell Biology and Toxicology (2024) Vol. 40, Iss. 1
Open Access | Times Cited: 3
Reliability of Metformin’s protective effects against doxorubicin-induced cardiotoxicity: a meta-analysis of animal studies
Ming‐Li Sun, Wei Chen, Xinghe Wang
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
Pro-oncogene FBI-1 inhibits the ferroptosis of prostate carcinoma PC-3 cells via the microRNA-324-3p/GPX4 axis
Liu Ming-sheng, Chenxiang Xu, Hua Yang, et al.
Journal of Cancer (2024) Vol. 15, Iss. 13, pp. 4097-4112
Open Access | Times Cited: 2
Metformin-mediated protection against doxorubicin-induced cardiotoxicity
Ming‐Li Sun, Junfeng Dong, Chen Liu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117535-117535
Open Access | Times Cited: 2
Role of mesenchymal stem cells‐derived exosomes on inflammation, apoptosis, fibrosis and telocyte modulation in doxorubicin‐induced cardiotoxicity: A closer look at the structural level
Reda Abdelnasser Imam, Basma Emad Aboulhoda, Maha M Amer, et al.
Microscopy Research and Technique (2024) Vol. 87, Iss. 7, pp. 1598-1614
Closed Access | Times Cited: 1
Mechanistic insights into carvedilol's potential protection against doxorubicin-induced cardiotoxicity
Elsayed A. Elmorsy, Sameh Saber, Rabab S. Hamad, et al.
European Journal of Pharmaceutical Sciences (2024) Vol. 200, pp. 106849-106849
Open Access | Times Cited: 1
Mechanisms of doxorubicin-induced cardiac inflammation and fibrosis; therapeutic targets and approaches
Linghua Song, Qingzhuo Qiu, Fei Ju, et al.
Archives of Biochemistry and Biophysics (2024) Vol. 761, pp. 110140-110140
Closed Access | Times Cited: 1
Small Molecules Targeting Mitochondria: A Mechanistic Approach to Combating Doxorubicin-Induced Cardiotoxicity
Chinmay Pal
Cardiovascular Toxicology (2024)
Closed Access | Times Cited: 1
A Novel Aniline Derivative from Peganum harmala L. Promoted Apoptosis via Activating PI3K/AKT/mTOR-Mediated Autophagy in Non-Small Cell Lung Cancer Cells
Zhongnan Wu, Wen Li, Qing Tang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12626-12626
Open Access | Times Cited: 4
Elucidation for the pharmacological effects and mechanism of Shen Bai formula in treating myocardial injury based on energy metabolism and serum metabolomic approaches
Hongwei Song, Junling Ren, Le Yang, et al.
Journal of Ethnopharmacology (2023) Vol. 323, pp. 117670-117670
Closed Access | Times Cited: 3
Anti-Diabetic Therapies and Cancer: From Bench to Bedside
Dimitris Kounatidis, Natalia G. Vallianou, Ιrene Karampela, et al.
Biomolecules (2024) Vol. 14, Iss. 11, pp. 1479-1479
Open Access
Mechanism of action of miR-15b-5p in alleviating asthma airway remodeling through the HMGB1/TLR4/IL-33 signaling axis
Wan-Ting Liu, Liangchang Li, Yihua Piao, et al.
International Immunopharmacology (2024) Vol. 145, pp. 113753-113753
Closed Access
Omega 3 fish oil-based lipid nanocapsules augment the therapeutic effects of vitamin D3 in a rat model of doxorubicin-induced cardiotoxicity
Lobna M.M.A. Abd El Mottelib, Eman M.M. Shehata, Heba F. Ibrahim, et al.
Journal of Drug Delivery Science and Technology (2024), pp. 106536-106536
Closed Access
Sodium-glucose cotransporter 2 inhibitor Dapagliflozin prevents ejection fraction reduction, reduces myocardial and renal NF-κB expression and systemic pro-inflammatory biomarkers in models of short-term doxorubicin cardiotoxicity
Vincenzo Quagliariello, Maria Laura Canale, Irma Bisceglia, et al.
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top